What Is Ketamine? Drug Class, Schedule & Drug Test Answers
Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated September 2026
Quick answer: Ketamine is a Dissociative anesthetic (NMDA antagonist). Schedule III (medical); esketamine Schedule III. Here's how the drug is classified, whether it's a narcotic/controlled substance, and what that means for testing.
What is Ketamine?
Drug class: Dissociative anesthetic (NMDA antagonist)
Federal schedule: Schedule III (medical); esketamine Schedule III.
Ketamine requires dedicated assays; standard employment cups omit it. Pain clinics, psychiatry (Spravato programs), and forensic settings order the specific test.
Is Ketamine a narcotic?
It is classified as a narcotic under the DEA's federal schedule. What matters more for you: Schedule III (medical); esketamine Schedule III..
Does it show up on drug tests?
No — it is not on the standard 5-panel; it appears only on expanded or panel-specific orders. See the full Ketamine drug test guide for detection windows and cutoffs.
False-positive caution
- Weak PCP-screen cross-reactivity documented at screen tier.
Certified labs nationwide · Results in 1–2 days
Need a test? Order online, test same-day →People also ask
Does Ketamine Show up on a Drug Test?
No — Ketamine is absent from standard drug panels. Full guide →
How Long Does Ketamine Stay in Your System Drug Test?
How long Ketamine stays detectable in your system (all test types) — urine, hair, saliva & blood windows explained with cutoffs. Full guide →
Ketamine Drug Test Guide: Panels, Detection Windows & More?
Complete Ketamine drug test guide: which panels detect it, urine/hair/saliva/blood detection windows, cutoff levels and prescription verification. Full guide →
How Long Does Ketamine Stay in Urine?
How long Ketamine stays detectable in urine — urine, hair, saliva & blood windows explained with cutoffs. Full guide →
Do prescriptions count against me?
No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.
Sources & further reading
- SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
- DOT — 49 CFR Part 40 procedures for transportation workplace testing
- Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
- FDA — drug-of-abuse test device labeling (detection window conventions)